Literature DB >> 11971940

Density distribution of electronegative LDL in normolipemic and hyperlipemic subjects.

José Luis Sánchez-Quesada1, Sonia Benítez, Carles Otal, Miquel Franco, Francisco Blanco-Vaca, Jordi Ordóñez-Llanos.   

Abstract

The density distribution of electronegative LDL [LDL(-)], a cytotoxic and inflammatory fraction of LDL present in plasma, was studied in 10 normolipemic (NL), 6 FH, and 11 hypertriglyceridemic (HTG) subjects. Six LDL subclasses of increased density (LDL1 to LDL6) were isolated by density-gradient ultracentrifugation (DGU). NL and FH subjects showed prevalence of light LDL, whereas HTG subjects showed prevalence of dense LDL. LDL(-) proportion was determined from total LDL or LDL-density subclasses by anion-exchange chromatography. LDL from FH patients had increased LDL(-) (35.1 +/- 9.9%) compared with LDL from NL and HTG subjects (9.4 +/- 2.3% and 12.3 +/- 4.3%, respectively). Most LDL(-) was contained in dense subclasses in NL (LDL4-6, 67.7 +/- 3.1%) whereas most of LDL(-) from FH patients were contained in light LDL subclasses (LDL1-3) (86.2 +/- 1.6%). In these subjects, simvastatin therapy decreased LDL(-) to 28.2 +/- 6.7% and 21.2 +/- 5.6% at 3 and 6 months of treatment, respectively, due mainly to decreases in light LDL subclasses. In HTG subjects, half LDL(-) was contained in dense LDL subclasses (LDL4-6, 46.1 +/- 2.0%). Non-denaturing acrylamide gradient gel electrophoresis concurred with DGU data, as LDL(-) from NL showed a single band of lower size than non-electronegative LDL [LDL(+)], whereas LDL(-) from FH and HTG presented bands of greater size than its respective LDL(+). These results reveal the existence of light and dense LDL(-), indicate that hyperlipemia could promote the formation of light LDL(-) and suggest that LDL(-) could have different origins.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11971940

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  24 in total

1.  Electronegative low-density lipoprotein is associated with dense low-density lipoprotein in subjects with different levels of cardiovascular risk.

Authors:  Ana Paula de Queiroz Mello; Isis Tande da Silva; Aline Silva Oliveira; Valéria Sutti Nunes; Dulcineia Saes Parra Abdalla; Magnus Gidlund; Nágila Raquel Teixeira Damasceno
Journal:  Lipids       Date:  2010-06-24       Impact factor: 1.880

2.  Immunochemical analysis of the electronegative LDL subfraction shows that abnormal N-terminal apolipoprotein B conformation is involved in increased binding to proteoglycans.

Authors:  Cristina Bancells; Sònia Benítez; Jordi Ordóñez-Llanos; Katariina Öörni; Petri T Kovanen; Ross W Milne; José L Sánchez-Quesada
Journal:  J Biol Chem       Date:  2010-11-15       Impact factor: 5.157

3.  Negatively charged low-density lipoprotein is associated with atherogenic risk in hypertensive patients.

Authors:  Jungo Urata; Satoshi Ikeda; Seiji Koga; Tomoo Nakata; Tomohiko Yasunaga; Koichiro Sonoda; Yuji Koide; Naoto Ashizawa; Shigeru Kohno; Koji Maemura
Journal:  Heart Vessels       Date:  2011-04-14       Impact factor: 2.037

4.  Effects of rosuvastatin on electronegative LDL as characterized by capillary isotachophoresis: the ROSARY Study.

Authors:  Bo Zhang; Akira Matsunaga; David L Rainwater; Shin-Ichiro Miura; Keita Noda; Hiroaki Nishikawa; Yoshinari Uehara; Kazuyuki Shirai; Masahiro Ogawa; Keijiro Saku
Journal:  J Lipid Res       Date:  2008-12-03       Impact factor: 5.922

5.  Aggregated electronegative low density lipoprotein in human plasma shows a high tendency toward phospholipolysis and particle fusion.

Authors:  Cristina Bancells; Sandra Villegas; Francisco J Blanco; Sonia Benítez; Isaac Gállego; Lorea Beloki; Montserrat Pérez-Cuellar; Jordi Ordóñez-Llanos; José Luis Sánchez-Quesada
Journal:  J Biol Chem       Date:  2010-07-29       Impact factor: 5.157

6.  The inflammatory properties of electronegative low-density lipoprotein from type 1 diabetic patients are related to increased platelet-activating factor acetylhydrolase activity.

Authors:  J L Sánchez-Quesada; S Benítez; A Pérez; A M Wagner; M Rigla; G Carreras; L Vila; M Camacho; R Arcelus; J Ordóñez-Llanos
Journal:  Diabetologia       Date:  2005-08-18       Impact factor: 10.122

7.  2D-NMR reveals different populations of exposed lysine residues in the apoB-100 protein of electronegative and electropositive fractions of LDL particles.

Authors:  Francisco J Blanco; Sandra Villegas; Sònia Benítez; Cristina Bancells; Tammo Diercks; Jordi Ordóñez-Llanos; José L Sánchez-Quesada
Journal:  J Lipid Res       Date:  2010-01-28       Impact factor: 5.922

8.  Thermal stability of human plasma electronegative low-density lipoprotein: A paradoxical behavior of low-density lipoprotein aggregation.

Authors:  Anna Rull; Shobini Jayaraman; Donald L Gantz; Andrea Rivas-Urbina; Montserrat Pérez-Cuellar; Jordi Ordóñez-Llanos; Jose Luis Sánchez-Quesada; Olga Gursky
Journal:  Biochim Biophys Acta       Date:  2016-05-24

9.  Dual roles for lipolysis and oxidation in peroxisome proliferation-activator receptor responses to electronegative low density lipoprotein.

Authors:  Ouliana Ziouzenkova; Liana Asatryan; Deanna Sahady; Gabriela Orasanu; Stephan Perrey; Benjamin Cutak; Tom Hassell; Taro E Akiyama; Joel P Berger; Alex Sevanian; Jorge Plutzky
Journal:  J Biol Chem       Date:  2003-07-23       Impact factor: 5.157

10.  Cloning and expression of an anti-LDL(-) single-chain variable fragment, and its inhibitory effect on experimental atherosclerosis.

Authors:  Soraya M Kazuma; Marcela F Cavalcante; Andréia E R Telles; Andrea Queiroz Maranhão; Dulcineia S P Abdalla
Journal:  MAbs       Date:  2013-07-25       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.